Moreau Richard
Laboratoire d' Hémodynamique Splanchnique et de Biologie Vasculaire, INSERM U-481, and Service d' Hépatologie, Hôpital Beaujon, Clichy, France.
J Gastroenterol Hepatol. 2002 Jul;17(7):739-47. doi: 10.1046/j.1440-1746.2002.02778.x.
Type 1 hepatorenal syndrome (HRS) is a severe complication of end-stage cirrhosis. Type 1 HRS is an acute functional renal failure (i.e. glomerular hypofiltration) with no other explanation than the presence of the circulatory and neurohumoral alterations associated with severe chronic liver disease. Plasma volume expansion does not improve renal function. In contrast, administration of the vasopressin analog terlipressin, a splanchnic and systemic vasoconstrictor, may improve renal function and be used while awaiting liver transplantation.
1型肝肾综合征(HRS)是终末期肝硬化的严重并发症。1型HRS是一种急性功能性肾衰竭(即肾小球滤过功能减退),除了存在与严重慢性肝病相关的循环和神经体液改变外,没有其他原因可以解释。血浆容量扩充并不能改善肾功能。相比之下,给予血管加压素类似物特利加压素(一种内脏和全身血管收缩剂)可能会改善肾功能,并可在等待肝移植期间使用。